Analysis of incidence and mortality of esophageal cancer in China, 2015;2015 年中国食管癌发病和死亡情况分析

Chinese Journal of Preventive Medicine

Volumn 53, Issue 11, 2019, Pages 1094-1097

  Chen, Ru ^a   Zheng, Rongshou ^a   Zhang, Siwei ^a   Zeng, Hongmei ^a   Wang, Shaoming ^a   Sun, Kexin ^c   Gu, Xiuying ^b   Wei, Wenqiang ^a   He, Jie ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c NONE

Author keywords

Cancer registry; Esophageal neoplasms; Incidence; Mortality; Surveillance

Indexed keywords

EID: 85194401101     PISSN: 02539624     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-9624.2019.11.004     Document Type: Article

References (15)

1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394⁃424. DOI: org / 10.3322 / caac.21492.
2. Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[EB/OL]. [2019⁃08⁃23]. https://www.sciencedirect.com/science/article/pii/S0140673619304271.
3. Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003⁃2015: a pooled analysis of 17 population⁃based cancer registries[J]. Lancet Glob Health, 2018,6(5):e555⁃e567. DOI: 10.1016/S2214⁃109X(18)30127⁃X.
4. 国家癌症中心 . 中国肿瘤登记工作指导手册(2016)[M]. 北京: 人民卫生出版社, 2016.
5. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness[J]. Eur J Cancer,2009,45(5):747⁃755. DOI: 10.1016/j.ejca.2008.11.032.
6. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness[J]. Eur J Cancer, 2009, 45(5): 756⁃764. DOI: 10.1016 / j. ejca.2008.11.033.
7. Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer[J]. The lancet, 2017,390(10110):2383⁃2396.
8. 赫捷. 2018中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2019.
9. Abnet CC, Arnold M, Wei WQ. Epidemiology of Esophageal Squamous Cell Carcinoma[J]. Gastroenterology, 2018, 154(2): 360⁃373. DOI: 10.1053/j.gastro.2017.08.023.
10. Wang JB, Fan JH, Liang H, et al. Attributable causes of esophageal cancer incidence and mortality in China[J]. PLoS One, 2012,7(8):e42281. DOI: 10.1371/journal.pone.0042281.
11. 左婷婷,郑荣寿,曾红梅,等 . 中国食管癌发病状况与趋势分析[J]. 中华肿瘤杂志, 2016,38(9):703⁃708. DOI:10.3760/cma. j.issn.0253⁃3766.2016.09.013.
12. 张思维,郑荣寿,左婷婷,等 . 中国食管癌死亡状况和生存分析[J]. 中华肿瘤杂志, 2016,38(9):709⁃715. DOI:10.3760/cma. j.issn.0253⁃3766.2016.09.014.
13. He Z, Liu Z, Liu M, et al. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population⁃based randomised controlled trial[J]. Gut,2019,68(2):198⁃206. DOI: 10.1136/gutjnl⁃2017⁃315520.
14. Wei WQ, Chen ZF, He YT, et al. Long⁃term follow⁃up of a community assignment, one⁃time endoscopic screening study of esophageal cancer in china[J]. J Clin Oncol, 2015; 33(17): 1951⁃1957. DOI: 10.1200/JCO.2014.58.0423.
15. 刘曙正, 于亮, 李变云, 等 . 林州市食管癌筛查病例与非筛查病例生存情况比较[J]. 中华预防医学杂志,2018,52(3): 238⁃242. DOI: 10.3760/cma.j.issn.0253⁃9624.2018.03.005.